Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  4,293 results for ""COVID-19 prevention & control""

Your Filters

Filter by : Subject Phrase Subject : sars-cov-2
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Nasal delivery of encapsulated recombinant ACE2 as a prophylactic drug for SARS-CoV-2.

  • Authors : Baldelli A; Faculty of Land and Food Systems, The University of British Columbia, Canada; School of Agriculture and Food Sustainability, The University of Queensland, Australia. Electronic address: .

Subjects: SARS-CoV-2* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

  • Source: International journal of pharmaceutics [Int J Pharm] 2024 Apr 25; Vol. 655, pp. 124009. Date of Electronic Publication: 2024 Mar 16.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Hybrid Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 During Pregnancy Provides More Durable Infant Antibody Responses Compared to Natural Infection or Vaccination Alone.

  • Authors : LaCourse SM; Division of Allergy and Infectious Diseases, Department of Medicine.; Department of Global Health.

Subjects: SARS-CoV-2* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Infant

  • Source: The Journal of infectious diseases [J Infect Dis] 2024 Apr 12; Vol. 229 (4), pp. 1241-1243.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The effect of SARS-COV-2 variant on non-respiratory features and mortality among vaccinated and non-fully vaccinated patients.

  • Authors : Cotton SA; University of California, Irvine, School of Nursing, 854 Health Sciences Rd, Irvine, CA 92697, USA; University of California, Irvine, Department of Computer Science, Donald Bren Hall, 6210, Irvine, CA 92697, USA. Electronic address: .

Subjects: SARS-CoV-2* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans SARS-CoV-2 variants

  • Source: Vaccine [Vaccine] 2024 Apr 11; Vol. 42 (10), pp. 2655-2660. Date of Electronic Publication: 2024 Mar 14.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals.

  • Authors : Urschel R; Department of Transplant and Infection Immunology, Saarland University, 66421, Homburg, Germany.; Bronder S

Subjects: SARS-CoV-2* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

  • Source: Nature communications [Nat Commun] 2024 Apr 09; Vol. 15 (1), pp. 3077. Date of Electronic Publication: 2024 Apr 09.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Characteristics of primary care practices by proportion of patients unvaccinated against SARS-CoV-2: a cross-sectional cohort study.

  • Authors : Shuldiner J; Women's College Hospital Institute of Virtual Care and Systems Solutions (Shuldiner, Tadrous, Ivers), Women's College Hospital, Toronto, Ont.; Departments of Family Medicine and Public Health Sciences (Green, Kerr), Queen's University, Kingston, Ont.

Subjects: SARS-CoV-2* ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2024 Apr 07; Vol. 196 (13), pp. E432-E440. Date of Electronic Publication: 2024 Publisher: Canadian Medical Association Country of Publication: Canada NLM ID: 9711805 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Neutralizing antibody responses to the Delta variant of SARS-CoV-2 following vaccination with Ad5-nCoV (CanSino) in the Mexican population.

  • Authors : Hernández-Bello J; Instituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud Universidad de Guadalajara, Guadalajara, Mexico.; Lorenzo-Leal AC

Subjects: SARS-CoV-2* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans SARS-CoV-2 variants

  • Source: PloS one [PLoS One] 2024 Apr 04; Vol. 19 (4), pp. e0299520. Date of Electronic Publication: 2024 Apr 04 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Determinants of health as predictors for differential antibody responses following SARS-CoV-2 primary and booster vaccination in an at-risk, longitudinal cohort.

  • Authors : Echeverri Tribin F; Department of Biomedical Engineering, University of Miami, Miami, Florida, United States of America.; University of Miami Miller School of Medicine, Miami, Florida, United States of America.

Subjects: SARS-CoV-2* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Female

  • Source: PloS one [PLoS One] 2024 Apr 02; Vol. 19 (4), pp. e0292566. Date of Electronic Publication: 2024 Apr 02 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

RaptGen-Assisted Generation of an RNA/DNA Hybrid Aptamer against SARS-CoV-2 Spike Protein.

  • Authors : Adachi T; RIBOMIC Inc., 3-16-13 Shirokanedai, Minato-ku, Tokyo 108-0071, Japan.; Nakamura S

Subjects: Aptamers, Nucleotide* ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/chemistry ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics

  • Source: Biochemistry [Biochemistry] 2024 Apr 02; Vol. 63 (7), pp. 906-912. Date of Electronic Publication: 2024 Mar 08.Publisher: American Chemical Society Country of Publication: United States NLM ID: 0370623 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Prophylactic effect of ensitrelvir in mice infected with SARS-CoV-2.

  • Authors : Nobori H; Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan. Electronic address: .; Baba K

Subjects: SARS-CoV-2* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Indazoles*

  • Source: Antiviral research [Antiviral Res] 2024 Apr; Vol. 224, pp. 105852. Date of Electronic Publication: 2024 Feb 28.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Duration of SARS-CoV-2 Culturable Virus Shedding in Children by Vaccination Status-Reply.

  • Authors : Kumar N; University Park Campus, University of Southern California, Los Angeles.; Bendavid E

Subjects: SARS-CoV-2* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Child

  • Source: JAMA pediatrics [JAMA Pediatr] 2024 Apr 01; Vol. 178 (4), pp. 421.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589544 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  4,293 results for ""COVID-19 prevention & control""